The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 80 (high attention) · dilution pressure high · listing risk elevated · governance risk low · runway 20.5 mo · strongest signal: Offering (424B) (Sep 4, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (negative equity) coexists with live selling machinery (atm program, convertible note, pipe, offering (424b)). Base case is a discounted raise; the question is when, not if.
Variable-priced paper is outstanding while the listing is under stress — the structure where dilution can accelerate. Watch the share count each quarter. Discount-priced or variable-priced securities are outstanding while the company is managing its listing with reverse splits/notices. Each conversion lowers the price, which lowers the next conversion price.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 84 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 21, 2026 | ▼ Convertible note | “convertible note” language in 8-K (EX-10.2) filed 2026-09-21 filing | 45 |
| Sep 21, 2026 | ▼ Reverse split | “reverse split” language in 8-K (EX-10.2) filed 2026-09-21 filing | 35 |
| Sep 21, 2026 | ▼ PIPE | “pipe” language in 8-K (8-K) filed 2026-09-21 filing | 33 |
| Sep 8, 2026 | · 13D amendment | Schedule 13D/A filed 2026-09-08 filing | 24 |
| Sep 4, 2026 | ▼ Offering (424B) | 424B5 prospectus supplement 2026-09-04; 1 prior 424B filings in 12m filing | 49 |
| Sep 4, 2026 | ▼ ATM program | “atm” language in 424B5 (424B5) filed 2026-09-04 filing | 40 |
| Jun 30, 2026 | ▼ Negative equity | Stockholders' equity $-382,000 as of 2026-06-30 filing | 31 |
| Jun 30, 2026 | ▼ Near $5M MVLS floor | Public float $2,767,603 (as of 2025-06-30) vs $5M Nasdaq MVLS floor; needs price x shares confirmation filing | 29 |
SDST Stardust Power Inc. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · SNTI Senti Biosciences Holdings, · GCTK Glucotrack, Inc. · SOAR Volato Group, Inc. · screener →